Rexta
Brand Name: Rexta
Generic Name: Oxaliplatin
Active
Registration Number
DR-XY48687
Dosage Form
Concentrate Solution for I.V. Infusion
Issuance Date
April 1, 2025
Expiry Date
March 31, 2031
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength5 mg/mL (50 mg/10 mL)
Packaging10 mL (net content) Type I clear and colorless glass vial with grey bromobutyl rubber stopper and aluminum seal with white polypropylene flip-off cap (Box of 1's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic Agent (Platinum Compound)
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
OxaliplatinActive
Monograph: Oxaliplatin